Artiva Biotherapeutics, Inc. Common Stock (ARTV)

9.97

(-9.69%)

Net Income Summary of Artiva Biotherapeutics, Inc. Common Stock

  • Artiva Biotherapeutics, Inc. Common Stock's latest annual net income in 2023 was -27.69 Million USD , up 52.57% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock's latest quarterly net income in 2024 Q1 was -13.96 Million USD , down -27.24% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported an annual net income of -58.38 Million USD in 2022, up 18.71% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported an annual net income of -71.82 Million USD in 2021, down -299.23% from previous year.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly net income of -13.96 Million USD for 2024 Q1, down -27.24% from previous quarter.
  • Artiva Biotherapeutics, Inc. Common Stock reported a quarterly net income of -27.69 Million USD for 2023 FY, up 52.57% from previous quarter.

Annual Net Income Chart of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Historical Annual Net Income of Artiva Biotherapeutics, Inc. Common Stock (2023 - 2020)

Year Net Income Net Income Growth
2023 -27.69 Million USD 52.57%
2022 -58.38 Million USD 18.71%
2021 -71.82 Million USD -299.23%
2020 -17.99 Million USD 0.0%

Peer Net Income Comparison of Artiva Biotherapeutics, Inc. Common Stock

Name Net Income Net Income Difference